Comparison of preferences of healthcare professionals and MS patients for attributes of disease-modifying drugs: A best-worst scaling

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)171-180
Number of pages10
JournalHealth Expectations
Volume21
Issue number1
DOIs
Publication statusPublished - 1 Feb 2018

Keywords

  • multiple sclerosis
  • best-worst scaling
  • healthcare professionals
  • disease-modifying drugs
  • shared decision making
  • patients
  • DISCRETE-CHOICE EXPERIMENT
  • MULTIPLE-SCLEROSIS
  • CONJOINT-ANALYSIS
  • DECISION-MAKING
  • THERAPY

Cite this